Dividend stocks are having an excellent October as tech sector struggles
ETFs focused on dividend stocks are seeing a powerful rally in October, adding to huge gains in 2026.
ETFs focused on dividend stocks are seeing a powerful rally in October, adding to huge gains in 2026.
CrowdStrike at Citi’s 2026 Global TMT Conference: AI fuels growth
“We really do earnestly believe AI could kill all humans!”, says Anthropic researcher Evan Hubinger on X. He thinks there is more than a 10% chance we could all be dead “within the next decade”. Talk of AI’s apocalyptic potential is in the air. Senior figures at AI labs are said to be terrified by…
Robert I. Blum, president & CEO of Cytokinetics, Incorporated (CYTK 0.43%), reported a sale of 7,500 shares of common stock on July 13, 2026, according to an SEC Form 4 filing. Transaction summary Metric Value Transaction value $615,150 Shares sold 7,500 Post-transaction shares (directly held) 377,820 Post-transaction shares (indirectly held) 4,166 Post-transaction value $31.41 million…
SHANGHAI, Aug. 11, 2026 /PRNewswire/ — Laekna (2105.HK) announced today that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) for the treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer (LA/mBC) with PIK3CA/AKT1/PTEN alterations, following recurrence…
Aprea Therapeutics plans Q4 2026 data update for APR-1051 trial
Bitcoin trapped in $76K-$82K range: Live levels